Antiverse raises £1.4 million ($2 million USD) to advance its AI antibody drug discovery platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding totalling £1.4 million ($2 million USD), comprising new investment and […]